New MRI technique could sharpen epilepsy surgery targeting
NCT ID NCT07316972
First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tests a new MRI method (CEST) to measure brain chemicals like glucose and glutamate in people with drug-resistant temporal lobe epilepsy who are candidates for surgery. The goal is to see if these chemical maps can more precisely identify the brain region causing seizures, potentially improving surgical outcomes. Twenty participants will undergo CEST scans, and results will be compared with standard pre-surgical evaluations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY (TREATMENT REFRACTORY) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.